polycystic ovary syndrome affects 1 in 10 women ofchildbearing age. The exact cause of the condition is unknown; however,obesity, high levels of inflammation and insulin resistance are the common riskfactors
Roots Analysis is pleased to announce the publication of its recentstudy, titled, “Polycystic Ovary Syndrome Market, 2021-2031.”
The report features an extensive study of the currentmarket landscape, offering an informed opinion on the likely adoption of thesetherapies over the next decade. It features an in-depth analysis, highlightingthe capabilities of various stakeholders engaged in this domain. In addition toother elements, the study includes:
§ A detailed assessmentof the therapeutic pipeline activity and therapeutic assessment of theproducts.
§ Detailed profiles ofthe players that are engaged in the development of drug products / therapiesfor polycystic ovarian syndrome.
§ An insightful marketassessment summary, highlighting the clinical and commercial attractiveness ofpipeline molecules (phase II and phase III).
§ A detailed analysisidentifying the key opinion leaders (KOLs), featuring a 2X2 analysis to assessthe relative experience of certain KOLs.
§ An insightfulanalysis of the patents filed / granted for polycystic ovary syndrome, since 2016, taking into considerationvarious parameters.
§ An in-depth analysisof grants awarded to various research institutes for the projects related topolycystic ovary syndrome, in the period between 2016 and April 2021.
§ A detailed analysisof completed, ongoing and planned clinical studies, based on the variousrelevant parameters.
§ A detailed market forecast, featuring analysis of thecurrent and projected future opportunity across key market segments (listedbelow)
§ Drug Class
§ Insulin Sensitizing Agents
§ Oral Contraceptives
§ Anti-Androgens
§ Anti-Obesity
§ Route of Administration
§ Oral
§ Subcutaneous
§ Intravenous
§ Others
§ Regional Distribution
§ North America (US, Canada)
§ Europe (France, Germany, Italy, Spain, UK)
§ Asia-Pacific and Rest of the World (Australia, China, Indiaand Japan)
Keycompanies covered in the report
§ AbbVie
§ Bayer
§ GlaxoSmithKline
§ Lupin Pharmaceuticals
§ Merck
§ Pfizer
§ Takeda
§ Teva Pharmaceuticals
Formore information please click on the following link:
https://www.rootsanalysis.com/reports/polycystic-ovarian-syndrome-market.html
Other Recent Offerings
1. Non-hormonal Therapiesfor Women’s Health Market, 2021-2030
2. Squamous Non-Small Cell Lung Cancer: Pipeline Review,Developer Landscape and Competitive Insights, 2021-2031
3. Vascular Disrupting Agents Market,2021-2030
About Roots Analysis
Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
Contact Information
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
